Browse our anti-E-cadherin (CDH1) Antibodies

Full name:
anti-Cadherin 1, Type 1, E-Cadherin (Epithelial) Antibodies (CDH1)
On are 800 Cadherin 1, Type 1, E-Cadherin (Epithelial) (CDH1) Antibodies from 39 different suppliers available. Additionally we are shipping E-cadherin Kits (80) and E-cadherin Proteins (38) and many more products for this protein. A total of 944 E-cadherin products are currently listed.
AA960649, arc-1, Arc1, b-cadherin, cadherin-1, cd324, cdh1, cdh1-a, cdhc-A, cdhe, cdhp, E-cad, E-cadherin, ecad, hjmd, L-CAM, LCAM, pcad, si:dz180o5.2, Um, UVO, uvomorulin, xb-cad, XB-cadherin, XBcad, xcdh1, XTCAD-1
list all antibodies Gene Name GeneID UniProt
CDH1 444901  
CDH1 12550 P09803
CDH1 999 P12830

Show all species

Show all synonyms

All available anti-E-cadherin Antibodies

Go to our pre-filtered search.

Top referenced anti-E-cadherin Antibodies

  1. Human Polyclonal E-cadherin Primary Antibody for FACS, IF (cc) - ABIN1387847 : Chen, Cheng, Chen, Sue, Liu, Cheng, Hsu, Chen: MicroRNA-328 inhibits renal tubular cell epithelial-to-mesenchymal transition by targeting the CD44 in pressure-induced renal fibrosis. in PLoS ONE 2014 (PubMed)
    Show all 4 references for 1387847

  2. Human Polyclonal E-cadherin Primary Antibody for FACS, WB - ABIN388278 : Hsu, Chen, Chou, Tang, Chen, Wilkins, Ellory, Shen: KCl cotransporter-3 down-regulates E-cadherin/beta-catenin complex to promote epithelial-mesenchymal transition. in Cancer research 2007 (PubMed)
    Show all 3 references for 388278

  3. Human Monoclonal E-cadherin Primary Antibody for IHC (p) - ABIN180686 : Bukholm, Nesland, Børresen-Dale: Re-expression of E-cadherin, alpha-catenin and beta-catenin, but not of gamma-catenin, in metastatic tissue from breast cancer patients [seecomments]. in The Journal of pathology 2000 (PubMed)
    Show all 3 references for 180686

  4. Human Monoclonal E-cadherin Primary Antibody for FACS - ABIN4895832 : Giron-Michel, Azzi, Khawam, Mortier, Caignard, Devocelle, Ferrini, Croce, François, Lecru, Charpentier, Chouaib, Azzarone, Eid: Interleukin-15 plays a central role in human kidney physiology and cancer through the γc signaling pathway. in PLoS ONE 2012 (PubMed)
    Show all 3 references for 4895832

  5. Mouse (Murine) Monoclonal E-cadherin Primary Antibody for FACS - ABIN4895839 : Liu, Tuve, Persson, Beyer, Yumul, Li, Tragoolpua, Hellström, Roffler, Lieber: Adenovirus-mediated intratumoral expression of immunostimulatory proteins in combination with systemic Treg inactivation induces tumor-destructive immune responses in mouse models. in Cancer gene therapy 2011 (PubMed)
    Show all 2 references for 4895839

  6. Human Monoclonal E-cadherin Primary Antibody for IHC (fro), IF - ABIN1106274 : Umbas, Schalken, Aalders, Carter, Karthaus, Schaafsma, Debruyne, Isaacs: Expression of the cellular adhesion molecule E-cadherin is reduced or absent in high-grade prostate cancer. in Cancer research 1992 (PubMed)
    Show all 2 references for 1106274

  7. Human Monoclonal E-cadherin Primary Antibody for FACS - ABIN4895826 : Vijayaragavan, Szabo, Bossé, Ramos-Mejia, Moon, Bhatia: Noncanonical Wnt signaling orchestrates early developmental events toward hematopoietic cell fate from human embryonic stem cells. in Cell stem cell 2009 (PubMed)

  8. Cow (Bovine) Polyclonal E-cadherin Primary Antibody for IF, IHC - ABIN2784498 : Onder, Gupta, Mani, Yang, Lander, Weinberg: Loss of E-cadherin promotes metastasis via multiple downstream transcriptional pathways. in Cancer research 2008 (PubMed)

More Antibodies against E-cadherin Interaction Partners

Xenopus laevis Cadherin 1, Type 1, E-Cadherin (Epithelial) (CDH1) interaction partners

  1. E-cadherin has a role in cranial neural crest migration in Xenopus laevis

  2. the switch from E- to N-cadherin (show CDH2 Antibodies) during epithelial-mesenchymal transition is essential for acquisition of Contact inhibition of locomotion behavior.

  3. Moderate attenuation of C-cadherin function affects cell adhesion but not gastrulation.

  4. Because paraxial protocadherin and C-cadherin do not directly interact nor form a joint complex with Fz7, Wnt-11 triggers formation of two distinct complexes that act in parallel to reduce cell adhesion by hampering clustering of C-cadherin.

  5. The functional and physical relationships between PAPC, FLRT3, and C-cadherin, was investigated.

  6. PAPC mediates these functions by down-regulating the adhesion activity of C-cadherin.

  7. Results suggest that the basis for cell segregation during morphogenesis does not map exclusively to protein-level differences in E-, N-, or C-cadherin adhesion.

  8. G-protein-coupled receptors control cortical actin assembly by controlling the amount of cadherin expressed on the cell surface.

  9. Two stage cadherin kinetics require multiple extracellular domains but not the cytoplasmic region

  10. Data show that the intracellular domain of PAPC (Protocadherin) interacts with Sprouty (Spry), and upon binding to PAPC, Spry function is inhibited and PCP signaling is enhanced.

Mouse (Murine) Cadherin 1, Type 1, E-Cadherin (Epithelial) (CDH1) interaction partners

  1. The expression level of E-cadherin protein was significantly decreased in fibrotic livers.

  2. We conclude that p120ctn (show CTNND1 Antibodies) is not only an adaptor and regulator of E-cadherin, but is also indispensable for proper lineage commitment.

  3. The reduction in tumor growth in fat1 (show FAT1 Antibodies) mice compared with wildtype controls may have been associated, in part, to the: i) Increased expression of Ecadherin and the reduced expression of its transcriptional repressors.

  4. These observations suggest that the overexpression of CatE (show CTSE Antibodies) interferes with neuronal differentiation of P19 (show CDKN2D Antibodies) cells through an impairment of cell aggregate formation, possibly through proteolytic degradation of N-cadherin (show CDH2 Antibodies).

  5. E-cadherin-mediated cell-cell contacts can modulate osteoclast-specific gene expression and prompt differentiating osteoclast precursors toward migratory and fusion activities.

  6. These results provide a new mechanism by which LXA4 inhibits LPS (show TLR4 Antibodies)-induced ALI through Nrf2 (show NFE2L2 Antibodies)-mediated E-cadherin expression

  7. Demonstrate that HBx-HCCR-E-cadherin regulation pathway might play an important role in HBV-induced hepatocarcinogenesis.

  8. E-cadherin expression regulates inflammatory mediators in macrophages.

  9. Increased expression of E-cadherin binds to and sequesters beta-catenin (show CTNNB1 Antibodies) away from downstream Wnt (show WNT2 Antibodies) signaling proteins.

  10. Results suggest a regulatory function of E-cadherin that modulates Nrg1 (show NRG1 Antibodies) signaling and promotes Schwann cell myelin formation

Human Cadherin 1, Type 1, E-Cadherin (Epithelial) (CDH1) interaction partners

  1. ESE3 (show EHF Antibodies) as a negative regulator of pancreatic ductal adenocarcinomas (PDAC) progression and metastasis by enforcing E-cadherin upregulation.

  2. Data indicate that ellagic aicd (EA) down-regulates the expression of COX-2 (show COX2 Antibodies), NF-kappa B (show NFKB1 Antibodies), vimentin (show VIM Antibodies) and up-regulates the expression of E-cadherin in in pancreatic carcinom PANC-1 cells.

  3. Data show that paired box gene 5 (B-cell lineage specific activator (show PAX5 Antibodies)) protein (Pax-5 (show PAX5 Antibodies)) induces E-cadherin expression in breast cancer cells.

  4. High RAS-associated protein (show RGL2 Antibodies) RAB5 (show RAB5A Antibodies) expression correlated with the presence of lymphatic invasion and venous invasion and low E-cadherin expression.

  5. Data suggest ATM (show ATM Antibodies) and E-cadherin expression as potential supportive predictive markers for EGFR (show EGFR Antibodies)-targeted therapy.

  6. cortactin (show CTTN Antibodies) binds to E-cadherin, and that a posttranslational modification of cortactin (show CTTN Antibodies), RhoA (show RHOA Antibodies)-induced phosphorylation by protein kinase D1 (PKD1; also known as PRKD1 (show PRKD1 Antibodies)) at S298, impairs adherens junction assembly and supports their dissolution.

  7. The expression level of E-cadherin in liver cirrhotic tissues were significantly lower than that in chronic hepatitis tissues.

  8. reduction of Alex3 (show ARMCX3 Antibodies) correlates with the development of non-small cell lung cancer and predicts adverse clinical outcome of non-small cell lung cancer patients. The effect of Alex3 (show ARMCX3 Antibodies) on inhibiting invasion and migration may attribute to upregulation of E-cadherin expression through AKT (show AKT1 Antibodies)-Slug (show SNAI2 Antibodies) pathway inactivation.

  9. overexpression of SPRY4 (show SPRY4 Antibodies)-IT1 (show HAUS3 Antibodies) increased E-cadherin and decreased N-cadherin (show CDH2 Antibodies) and vimentin (show VIM Antibodies) protein levels, indicating that SPRY4 (show SPRY4 Antibodies)-IT1 (show HAUS3 Antibodies) may regulate ovarian cancer cell metastasis through the inhibition of epithelial-mesenchymal transition.

  10. EHD2 (show EHD2 Antibodies) expression, along with the epithelial marker E-cadherin, was markedly reduced in tumor tissues than in adjacent noncancerous tissues. Molecular data indicated that EHD2 (show EHD2 Antibodies) inhibited migration and invasion of hepatocellular carcinoma probably by interacting with E-cadherin.

Pig (Porcine) Cadherin 1, Type 1, E-Cadherin (Epithelial) (CDH1) interaction partners

  1. E-cadherin mRNA/protein were up-regulated in all flutamide-treated corpus luteum of mid- and late pregnancy.

  2. In pig kidney, strong E-cadherin expression was observed in the basolateral plasma membrane of the tubular epithelial cells. E-cadherin immunolabeling was not detected in glomeruli or blood vessels of pig kidney.

  3. Localisation of NANOG (show NANOG Antibodies), OCT4 (show POU5F1 Antibodies), and E-CADHERIN in porcine pre- and peri (show PLIN1 Antibodies)-implantation embryos.

  4. The epiblast expressed epithelial markers, MUC1 (show MUC1 Antibodies) and E-CADHERIN, and the pluripotency markers, DNMT3B (show DNMT3B Antibodies) and CRIPTO (show TDGF1 Antibodies).

Cow (Bovine) Cadherin 1, Type 1, E-Cadherin (Epithelial) (CDH1) interaction partners

  1. Transfection of zygotes with 100 and 200 nM E-cadherin siRNA led to a 72 and 38% reduction, respectively, in E-cadherin mRNA relative abundance in Day 7 blastocysts compared with controls.

  2. E-cadherin and beta-catenin (show CTNNB1 Antibodies) were distributed not only at the cell to cell boundary but throughout the cytoplasm in binucleate trophoblast cells

  3. Results describe the effect of suppression of connexin 43 (show GJA1 Antibodies) and E-cadherin on the development, mRNA and protein expression of bovine blastocysts cultured in vitro or in vivo.

Zebrafish Cadherin 1, Type 1, E-Cadherin (Epithelial) (CDH1) interaction partners

  1. E-cadherin mRNA coinjection demonstrated the specificity of cdh1 morpholino oligonucleotides-induced defects

  2. Results suggest that Wnt11 (show WNT11 Antibodies) controls tissue morphogenesis by modulating E-cadherin-mediated cell cohesion through Rab5c (show Rab5c Antibodies), a novel mechanism of Wnt (show WNT2 Antibodies) signaling in gastrulation.

E-cadherin (CDH1) Antigen Profile

Antigen Summary

This gene is a classical cadherin from the cadherin superfamily. The encoded protein is a calcium dependent cell-cell adhesion glycoprotein comprised of five extracellular cadherin repeats, a transmembrane region and a highly conserved cytoplasmic tail. Mutations in this gene are correlated with gastric, breast, colorectal, thyroid and ovarian cancer. Loss of function is thought to contribute to progression in cancer by increasing proliferation, invasion, and/or metastasis. The ectodomain of this protein mediates bacterial adhesion to mammalian cells and the cytoplasmic domain is required for internalization. Identified transcript variants arise from mutation at consensus splice sites.

Alternative names and synonyms associated with E-cadherin (CDH1)

  • cadherin 3, type 1, P-cadherin (placental) (cdh3-a) antibody
  • Aerobic running capacity QTL 1 (Arunc1) antibody
  • cadherin 1 (Cdh1) antibody
  • cadherin 1, type 1, E-cadherin (epithelial) (CDH1) antibody
  • cadherin 1, type 1, E-cadherin (epithelial) (Cdh1) antibody
  • cadherin 1, type 1, E-cadherin (epithelial) (cdh1) antibody
  • E-cadherin-like (LOC100356548) antibody
  • si:busm1-180o5.2 (si:busm1-180o5.2) antibody
  • AA960649 antibody
  • arc-1 antibody
  • Arc1 antibody
  • b-cadherin antibody
  • cadherin-1 antibody
  • cd324 antibody
  • cdh1 antibody
  • cdh1-a antibody
  • cdhc-A antibody
  • cdhe antibody
  • cdhp antibody
  • E-cad antibody
  • E-cadherin antibody
  • ecad antibody
  • hjmd antibody
  • L-CAM antibody
  • LCAM antibody
  • pcad antibody
  • si:dz180o5.2 antibody
  • Um antibody
  • UVO antibody
  • uvomorulin antibody
  • xb-cad antibody
  • XB-cadherin antibody
  • XBcad antibody
  • xcdh1 antibody
  • XTCAD-1 antibody

Protein level used designations for CDH1

C-cadherin (EP-cadherin) , EP-cadherin , cadherin 1, type 1, E-cadherin (epithelial) , ARC-1 , E-cadherin , cadherin-1 , epithelial cadherin , uvomorulin , CAM 120/80 , E-Cadherin , cadherin 1, E-cadherin (epithelial) , calcium-dependent adhesion protein, epithelial , cell-CAM 120/80 , L-CAM , liver cell adhesion molecule , liver cell adhesion protein , xTCAD-1 , Epithelial cadherin , hypothetical protein LOC368517

394290 Xenopus laevis
444901 Rattus norvegicus
12550 Mus musculus
83502 Rattus norvegicus
999 Homo sapiens
442858 Canis lupus familiaris
100048953 Sus scrofa
282637 Bos taurus
415860 Gallus gallus
101095391 Felis catus
101119747 Ovis aries
100726210 Cavia porcellus
100337618 Xenopus laevis
100174439 Pongo abelii
100356548 Oryctolagus cuniculus
368517 Danio rerio
Selected quality suppliers for anti-E-cadherin (CDH1) Antibodies
Did you look for something else?